Just for the record Acadia already have the following arrangement in place with Stoke Therapeutics [which includes Rett Syndrome treatments] in place:
"SAN DIEGO & BEDFORD, Mass.–(BUSINESS WIRE)–Jan. 10, 2022– Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) and Stoke Therapeutics, Inc. (Nasdaq: STOK) announced today that the companies have entered a collaboration to discover, develop and commercialize novel RNA-based medicines for the potential treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system (CNS). The collaboration includes SYNGAP1 syndrome, Rett syndrome (MECP2), and an undisclosed neurodevelopmental target of mutual interest".
Kens
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
Neuren Media and Analyst Coverage, page-1310
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.13 |
Change
0.020(0.15%) |
Mkt cap ! $1.678B |
Open | High | Low | Value | Volume |
$13.20 | $13.44 | $13.07 | $5.021M | 378.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 11501 | $13.12 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.18 | 1539 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 464 | 13.100 |
2 | 264 | 13.070 |
1 | 300 | 13.020 |
2 | 300 | 13.010 |
9 | 17634 | 13.000 |
Price($) | Vol. | No. |
---|---|---|
13.210 | 1700 | 1 |
13.430 | 2400 | 1 |
13.450 | 150 | 1 |
13.480 | 2000 | 1 |
13.490 | 1700 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |